AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

5,209.00p
   
  • Change Today:
      24.00p
  • 52 Week High: 5,255.00p
  • 52 Week Low: 3,774.00p
  • Currency: UK Pounds
  • Shares Issued: 1,265.64m
  • Volume: 1,788,098
  • Market Cap: 65,927m
  • RiskGrade: 134
  • Beta: 1.01

AstraZeneca Overview

A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.

1 Day Chart

6 Month Chart

AstraZeneca Financials

Latest F'cast
Div Yield 4.1% 4.7%
Div Cover 1.5 1.3
Op Mrgn 23.0% 25.8%
ROCE n/a  
Latest F'cast
P/E 15.7 17.8
PEG 13.3 n/a
Pr/Revenue 4.0 3.9
Pr/Book 5.1  
Latest F'cast
Revenue -9.8% -38.9%
PBT 15.7% -5.3%
EPS 1.2% -11.9%
DPS n/a -40.0%

AstraZeneca Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-12 27,973.00 7,646.00 683.00¢ 5.5 n/a -6% 280.00¢ 7.4%
31-Dec-13 25,711.00 3,267.00 505.00¢ 9.2 n/a -26% 280.00¢ 6.1%
31-Dec-14 26,095.00 1,246.00 428.00¢ 13.8 n/a -15% 280.00¢ 4.7%
31-Dec-15 23,641.00 3,069.00 426.00¢ 14.0 n/a -0% 280.00¢ 4.7%
31-Dec-16 21,319.00 3,552.00 431.00¢ 13.3 13.3 +1% 280.00¢ 4.9%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

AstraZeneca Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-17 16,859.95 4,354.24 291.60p 17.9 n/a -12% 217.27p 4.7%
31-Dec-18 17,428.72 4,570.89 308.96p 16.9 2.8 +6% 219.49p 4.7%

Copyright © 2017 FactSet Research Systems Inc. All rights reserved.

Latest AstraZeneca Director Deals

Traded Action Notifier PriceAmountValue
15-May-17 Transfer To Pascal Soriot 0.000p 163,000 0.00
28-Mar-17 Transfer From Pascal Soriot 0.000p 101,584 0.00
28-Mar-17 Transfer From Marc Dunoyer 0.000p 25,478 0.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 5,209.00p
Change Today 24.00p
% Change 0.46 %
52 Week High 5,255.00p
52 Week Low 3,774.00p
Volume 1,788,098
Shares Issued 1,265.64m
Market Cap 65,927m
Beta 1.01
RiskGrade 134

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
63.85% below the market average63.85% below the market average63.85% below the market average63.85% below the market average63.85% below the market average
20.69% above the sector average20.69% above the sector average20.69% above the sector average20.69% above the sector average20.69% above the sector average
Price Trend
60.06% above the market average60.06% above the market average60.06% above the market average60.06% above the market average60.06% above the market average
58.06% above the sector average58.06% above the sector average58.06% above the sector average58.06% above the sector average58.06% above the sector average
Income
65.25% above the market average65.25% above the market average65.25% above the market average65.25% above the market average65.25% above the market average
63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average
Growth
52.64% below the market average52.64% below the market average52.64% below the market average52.64% below the market average52.64% below the market average
77.27% below the sector average77.27% below the sector average77.27% below the sector average77.27% below the sector average77.27% below the sector average

What The Brokers Say

Strong Buy 18
Buy 2
Neutral 13
Sell 0
Strong Sell 5
Total 38
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 16-Feb-17 11-Aug-16
Paid 20-Mar-17 12-Sep-16
Amount 190.00¢ 90.00¢

Trades for 25-May-2017

Time Volume / Share Price
17:02 16,036 @ 5,209.78p
17:02 400 @ 5,189.89p
17:02 110 @ 5,191.23p
17:01 1,294 @ 5,205.03p
17:01 165 @ 5,201.93p

Top of Page